Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Challenges in functional bowel disease.

M A Kamm1

  • 1Physiology Unit, St Mark's Hospital, London, UK.

The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement
|November 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn's disease. The ENIGMA study.

Gut microbes·2023
Same author

Letter: tofacitinib in biologic-experienced ulcerative colitis-a single-centre real-world experience in Australia.

Alimentary pharmacology & therapeutics·2021
Same author

Novel strain-level resolution of Crohn's disease mucosa-associated microbiota via an ex vivo combination of microbe culture and metagenomic sequencing.

The ISME journal·2021
Same author

Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.

Neurogastroenterology and motility·2018
Same author

Editorial: visceral fat as a predictor of post-operative recurrence of Crohn's disease-Authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Visceral adiposity predicts post-operative Crohn's disease recurrence.

Alimentary pharmacology & therapeutics·2017
Same journal

Cirrhosis--can we reverse hepatic fibrosis?

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·2005
Same journal

Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·2005
Same journal

Patient in focus: the way forward to promote wellbeing and delivery of health care in patients with gastro-oesophageal reflux disease.

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·2005
Same journal

GORD: long-term treatment with a proton pump inhibitor compared with operation.

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·2005
Same journal

Pharmacogenomics in gastrointestinal disorders.

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·2005
Same journal

Molecular epidemiology: a tool for understanding mechanisms of disease.

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·2005
See all related articles

Societal changes are increasing anxiety and depression, impacting functional bowel disorders. New therapeutic approaches require understanding the gut-brain axis and enhancing the "therapeutic team" with broader skills for better patient outcomes.

Area of Science:

  • Gastroenterology and Neuropsychiatry
  • Psychosomatic Medicine

Background:

  • Modern societal shifts correlate with rising anxiety and depression rates.
  • Functional bowel disorders (FBDs) are closely linked to psychological distress.
  • Current treatment paradigms for FBDs often overlook crucial psychosocial factors.

Purpose of the Study:

  • To advocate for a multidisciplinary
  • therapeutic team
  • approach to FBD management.
  • To highlight the need for deeper understanding of pathophysiological mechanisms in FBDs.
  • To explore novel therapeutic targets and strategies for FBDs.

Main Methods:

  • Review of current understanding of FBD pathophysiology.
  • Discussion of emerging neurochemical and molecular targets (e.g., GABA, NO, 5-HT4 agonists).

Related Experiment Videos

  • Exploration of the impact of chronic stress on gut function and autonomic control.

    • Main Results:

    • Elucidation of mechanisms in reflux disease suggests targeted interventions.
    • Specific agonists show promise for constipation and diarrhea.
    • Pain modulation in FBDs remains a challenging but critical area for research.

    Conclusions:

    • Integrating psychosocial factors and expanding the therapeutic team are essential for FBD treatment.
    • Further research into the gut-brain axis and neurochemical pathways will drive innovative therapies.
    • Improved clinical trial design and outcome measures are needed to evaluate FBD treatments effectively.